Description
Docemaps 80mg Injection is a potent medication containing the active ingredient Docetaxel, a semi-synthetic derivative of paclitaxel. It belongs to the taxane class of chemotherapy drugs. Docetaxel works by disrupting the microtubule network within cancer cells. Microtubules are essential for cell division and function. By stabilizing microtubules, Docemaps prevents their breakdown, leading to the arrest of cell division and ultimately programmed cell death (apoptosis) in rapidly dividing cancer cells. It is primarily indicated for the treatment of various types of cancer, including breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. The dosage and administration of Docemaps 80mg Injection should be strictly determined by a qualified healthcare professional based on the patient’s specific condition, response to treatment, and overall health. Common side effects may include myelosuppression (low blood cell counts), fatigue, nausea, vomiting, diarrhea, hair loss, fluid retention, and peripheral neuropathy. It is crucial to report any adverse reactions to your doctor immediately. Docemaps 80mg Injection should be stored at room temperature, protected from light, and kept out of reach of children.
